Teng Ko Ngooi

Title: The Innovations of Teng Ko Ngooi

Introduction

Teng Ko Ngooi is a notable inventor based in Mississauga, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of macrocyclic compounds. With a total of 2 patents to his name, his work has the potential to impact medical treatments significantly.

Latest Patents

Teng Ko Ngooi's latest patents include a synthetic process for the preparation of macrocyclic C1-keto analogs of halichondrin B and intermediates useful therein. This patent discloses a compound of formula 1, or a pharmaceutically acceptable salt thereof, where R, R, R, R, R, R, R, R, R, R, R, R, and R are defined as disclosed in the patent. The process for the preparation of this compound is also detailed, highlighting its utility in the preparation of halichondrin analogs, such as Eribulin.

Career Highlights

Throughout his career, Teng Ko Ngooi has worked with reputable companies in the pharmaceutical industry, including Alphora Research Inc. and Sandoz AG. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Some of his notable coworkers include Fabio E S Souza and Alena Rudolph. Their collaboration has likely fostered an environment of innovation and creativity in their respective projects.

Conclusion

Teng Ko Ngooi's contributions to the field of pharmaceuticals through his patents and collaborations demonstrate his commitment to advancing medical science. His work continues to pave the way for new treatments and innovations in the industry.